Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Beclometasone breath-activated inhalation - IVAX

Drug Profile

Beclometasone breath-activated inhalation - IVAX

Alternative Names: Beclazone 250 Easi-Breathe; Beclazone Easi-Breathe; Beclometasone breath-activated inhalation - Baker Norton; Beclometasone CFC-free Easi-Breathe; Beclomethasone breath-activated inhalation - Baker Norton; Beclomethasone breath-activated inhalation - IVAX; Beclomethasone CFC-free Easi-Breathe

Latest Information Update: 28 Jan 2014

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator IVAX Laboratories
  • Class Antiallergics; Antiasthmatics; Chlorinated steroids; Corticosteroids; Pregnadienetriols; Small molecules; Vascular disorder therapies
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Asthma

Most Recent Events

  • 01 Mar 2010 Withdrawn for Asthma in United Kingdom (Inhalation)
  • 01 Jul 2009 Withdrawn for Asthma in Mexico (Inhalation)
  • 01 Jan 2008 Withdrawn for Asthma in Czech Republic (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top